A Study of Ninlaro in Real World Clinical Practice in China
NCT04328662 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 482
Last updated 2026-03-04
Summary
The main purpose of this study is to collect additional safety information of ixazomib citrate (Ninlaro) when used to treat multiple myeloma in real world clinical practice in China. Participants will be treated with Ninlaro according to the normal clinical practice during this study.
Conditions
- Multiple Myeloma
- Neoplasms, Plasma Cell
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-18
- Primary Completion
- 2026-02-13
- Completion
- 2026-02-13
Countries
- China
Study Locations
More Related Trials
-
A Study of ILB2109 in Patients With Advanced Solid Malignancies
NCT05278546 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor
NCT05235438 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects
NCT02721589 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple Myeloma
NCT04121260 ·Status: COMPLETED ·Phase: PHASE1
-
QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors
NCT04326829 ·Status: UNKNOWN ·Phase: PHASE2
-
Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors
NCT02395068 ·Status: UNKNOWN ·Phase: PHASE1
-
The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma
NCT04356872 ·Status: UNKNOWN ·Phase: PHASE2
-
Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma
NCT05717790 ·Status: RECRUITING ·Phase: NA
-
Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer
NCT02577341 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of SM3321 With Solid Tumors
NCT06087770 ·Status: RECRUITING ·Phase: PHASE1
-
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06414460 ·Status: RECRUITING ·Phase: PHASE1
-
Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma
NCT03374007 ·Status: UNKNOWN ·Phase: PHASE1
-
Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells
NCT06302465 ·Status: RECRUITING ·Phase: NA
-
Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC
NCT02421640 ·Status: UNKNOWN ·Phase: PHASE2
-
Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT02434614 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors
NCT05990452 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors
NCT03171220 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm
NCT05048160 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of Pharmacokinetics, Safety, and Preliminary Efficacy of Isatuximab in Chinese Patients With Relapsed and/or Refractory Multiple Myeloma
NCT03733717 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC
NCT05054439 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS
NCT04635631 ·Status: COMPLETED ·Phase: PHASE1
-
Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma
NCT03984357 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Relatlimab in Combination With Nivolumab in Chinese Participants
NCT05498480 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer
NCT04426955 ·Status: UNKNOWN ·Phase: PHASE3
-
Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT05898256 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2